abstract |
An antibody that binds to human CCR5 comprising a variable heavy chain and a variable light chain, wherein said variable heavy chain is selected from the group consisting of CDR1, SEQ ID NOs: 13, 14, and 15 selected from the group consisting of SEQ ID NOs: 9, 10, 11, and 12 as CDR sequences An antibody, chimeric antibody, humanized variant or fragment thereof, wherein said CDR2 is selected from the group consisting of selected CDR2 and SEQ ID NOs: 16 and 17, wherein said CDRs are independently selected from one another, are advantageous for the treatment of an immunosuppressive disease. Has the nature. |